• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

1-1-(4-Chlorophenyl)-5-methyl-1H-pyrazol-4-ylethan-1-amine: A Comprehensive Overview

The compound 1-1-(4-Chlorophenyl)-5-methyl-1H-pyrazol-4-ylethan-1-amine (CAS No. 1152950-12-3) is a highly specialized organic compound with significant potential in various fields of chemistry and pharmacology. This compound has garnered attention due to its unique structural features and promising applications in drug discovery and material science. In this article, we delve into the structural characteristics, synthesis methods, and recent advancements in understanding its properties and uses.

Chemical Structure and Properties

The molecular structure of 1-1-(4-Chlorophenyl)-5-methyl-1H-pyrazol-4-ylethan-1-amine is characterized by a pyrazole ring fused with an ethanamine group and a 4-chlorophenyl substituent. The pyrazole ring, a five-membered heterocycle containing two nitrogen atoms, contributes to the compound's stability and reactivity. The presence of the 4-chlorophenyl group introduces electronic effects that can influence the compound's interactions with biological systems or other chemical entities.

Recent studies have highlighted the importance of such heterocyclic compounds in medicinal chemistry, particularly in the development of kinase inhibitors and other therapeutic agents. The methyl group at position 5 of the pyrazole ring adds further complexity to the molecule, potentially enhancing its pharmacokinetic properties such as bioavailability and metabolic stability.

Synthesis and Characterization

The synthesis of 1-1-(4-Chlorophenyl)-5-methyl-1H-pyrazol-4-ylethan-1-amine involves a multi-step process that typically begins with the preparation of intermediates such as substituted pyrazoles or anilines. Recent advancements in catalytic methods have enabled more efficient and selective syntheses, reducing production costs and minimizing environmental impact.

Characterization techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography have been employed to confirm the molecular structure and purity of this compound. These analyses are crucial for ensuring consistency in its application across different research settings.

Applications in Drug Discovery

One of the most promising areas for 1-(4-Chlorophenyl)-5-methylpyrazolium chloride is its potential use in drug discovery. Researchers have explored its ability to inhibit key enzymes involved in diseases such as cancer, inflammation, and neurodegenerative disorders. For instance, recent studies have demonstrated its inhibitory effects on tyrosine kinases, which are critical targets in oncology.

In addition to its enzymatic activity, this compound has shown potential as a lead molecule for developing new generations of antibiotics. Its unique structure allows for interactions with bacterial targets that are not addressed by current antibiotic therapies.

Structural Features and Biological Activity

The structural features of (E)-N'-(4-chlorophenyl)-N,N-dimethylbenzeneacetohydrazide play a pivotal role in determining its biological activity. The pyrazole ring's electron-withdrawing properties enhance the molecule's ability to form hydrogen bonds with target proteins, a critical factor in drug-receptor interactions.

Moreover, the methyl group at position 5 introduces steric hindrance that can modulate the compound's selectivity towards specific biological targets. This feature is particularly advantageous in designing drugs with high specificity and reduced off-target effects.

Future Directions

As research on (E)-N'-(4-chlorophenyl)-N,N-dimethylbenzeneacetohydrazide continues to expand, there is growing interest in exploring its applications beyond traditional pharmaceuticals. Potential avenues include its use in agrochemicals, where it could serve as a novel herbicide or fungicide component.

In conclusion, (E)-N'-(4-chlorophenyl)-N,N-dimethylbenzeneacetohydrazide (CAS No. 1152950) represents a versatile compound with significant potential across multiple disciplines. Its unique chemical structure, coupled with recent advancements in synthesis and characterization techniques, positions it as a valuable tool for future innovations in science and medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)